MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.43

-0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	5/31/2007 6:19:58 AM
	of 2240

Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma Thursday May 31, 6:00 am ET PRINCETON, N.J., May 31 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX - News) today announced a collaborative research agreement with Mitsubishi Pharma Corporation, a subsidiary of Mitsubishi Chemical Holdings Corporation. The two companies expect to generate and evaluate fully human monoclonal antibodies against a Mitsubishi target for the potential treatment of autoimmune diseases. The companies plan to use Medarex's UltiMAb Human Antibody Development System® to generate antibodies for research and possible development. Under the terms of the agreement, Medarex and Mitsubishi Pharma will share research responsibilities for any antibodies generated through the collaboration. Other terms of the agreement were not disclosed. "We are very much pleased to work with Medarex," said Dr. Tohru Nakajima, Executive Officer/Division Manager of the Pharmaceutical Research Division for Mitsubishi Pharma. "We will gain access to excellent expertise that provides us with the potential advancement of novel therapeutics for autoimmune diseases." "We are pleased to have this opportunity to partner with Mitsubishi Pharma Corporation and its research team and to work together to potentially discover new antibody therapeutics," said Irwin Lerner, Interim President and CEO of Medarex.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next